New eye drops could offer Needle-Free hope for diabetic vision loss
Disease control
Completed
This study tested an eye drop called INV-102 in 19 adults with diabetic macular edema (DME), a condition that causes vision loss in people with diabetes. The goal was to see if the drops can reduce swelling and improve eye health over 8 to 12 weeks. If successful, this could prov…
Phase: PHASE2 • Sponsor: Invirsa, Inc. • Aim: Disease control
Last updated Apr 24, 2026 16:07 UTC